KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Preferred Dividend Payments (2016 - 2018)

Teva Pharmaceutical Industries filings provide 4 years of Preferred Dividend Payments readings, the most recent being $54.0 million for Q4 2018.

  • On a quarterly basis, Preferred Dividend Payments fell 16.92% to $54.0 million in Q4 2018 year-over-year; TTM through Dec 2018 was $249.0 million, a 4.23% decrease, with the full-year FY2018 number at $249.0 million, down 4.23% from a year prior.
  • Preferred Dividend Payments hit $54.0 million in Q4 2018 for Teva Pharmaceutical Industries, down from $65.0 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $66000.0 billion in Q2 2016 to a low of $15.0 million in Q4 2015.
  • Median Preferred Dividend Payments over the past 4 years was $65.0 million (2016), compared with a mean of $10000.1 billion.
  • Biggest five-year swings in Preferred Dividend Payments: soared 333.33% in 2016 and later plummeted 100.0% in 2017.
  • Teva Pharmaceutical Industries' Preferred Dividend Payments stood at $15.0 million in 2015, then soared by 333.33% to $65.0 million in 2016, then changed by 0.0% to $65.0 million in 2017, then fell by 16.92% to $54.0 million in 2018.
  • The last three reported values for Preferred Dividend Payments were $54.0 million (Q4 2018), $65.0 million (Q3 2018), and $65.0 million (Q2 2018) per Business Quant data.